K
Kenneth J. Pienta
Researcher at Johns Hopkins University School of Medicine
Publications - 751
Citations - 72579
Kenneth J. Pienta is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 127, co-authored 671 publications receiving 64531 citations. Previous affiliations of Kenneth J. Pienta include Rutgers University & Harper University Hospital.
Papers
More filters
Journal ArticleDOI
Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted 18F-DCFPyL positron emission tomography/computed tomography: A unique visual pattern.
Yafu Yin,Channing J. Paller,Martin G. Pomper,Kenneth J. Pienta,Michael A. Gorin,Steven P. Rowe +5 more
TL;DR: A novel pattern of radiotracer uptake in a patient with PCa imaged with PSMA-targeted18F-DCFPyL positron emission tomography/computed tomography that is consistent with diffuse vas deferens involvement is described.
Journal ArticleDOI
Cells in the polyaneuploid cancer cell (PACC) state have increased metastatic potential
Mikaela M. Mallin,Nicholas Kim,Mohammad Ikbal Choudhury,Se Jong Lee,Steven S. An,Sean X. Sun,Konstantinos Konstantopoulos,Kenneth J. Pienta,Sarah R. Amend +8 more
TL;DR: In this article , the authors proposed that cells engaging a polyaneuploid cancer cell (PACC) phenotype are metastasis competent and showed that cells in the PACC state are enlarged, endocycling (i.e. non-dividing) cells with increased genomic content that form in response to stress.
Journal ArticleDOI
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
Richard C. Zieren,Richard C. Zieren,Liang Dong,Liang Dong,David J. Clark,Morgan D. Kuczler,Kengo Horie,Leandro F. Moreno,Tung-Shing M. Lih,Michael Schnaubelt,Louis Vermeulen,Hui Zhang,Theo M. de Reijke,Kenneth J. Pienta,Sarah R. Amend +14 more
TL;DR: In this article, the authors used Tandem Mass Tag mass spectrometry (TMT-MS) and NanoString nCounter technology to profile 770 cancer-related mRNA present in extracellular vesicles (EVs).